WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Republican Leader of the Energy and Commerce Committee’s Health Subcommittee, spoke on the House floor to support scheduling fentanyl analogues. Guthrie is a cosponsor of the Federal Initiative to Guarantee Health by Targeting Fentanyl Act, which would put fentanyl analogues permanently on the Drug Enforcement Administration’s Schedule I, contr... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Republican Leader of the Energy and Commerce Committee’s Health Subcommittee, introduced the Lower Costs, More Cures Act in the U.S. House of Representatives. The Lower Costs, More Cures Act is made of all bipartisan provisions, and last Congress, more than a dozen solutions from this bill were signed into law. “I introduced the Lower Costs, Mo... Read more »

WASHINGTON, D.C. – Energy and Commerce Committee’s Health Subcommittee Republican Leader Brett Guthrie (R-KY), Energy and Commerce Committee Republican Leader Cathy McMorris Rodgers (R-WA), Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) wrote to Health and Human Services (HHS) Secretary Xavier Becerra this week regarding im... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) this week joined a bipartisan group of lawmakers in introducing a comprehensive new bill to help families across the country dealing with Alzheimer’s disease. The Comprehensive Care for Alzheimer’s Act would help the 95% of individuals with dementia that have one or more other chronic conditions, such as hypertension, heart disease and diabetes.... Read more »

WASHINGTON, D.C. –Congressman Brett Guthrie (KY-02), Republican Leader of the Energy and Commerce Committee’s Health Subcommittee, and Congressman Kurt Schrader (OR-05), Health Subcommittee member, praised passage of their bipartisan solution to help lower drug costs in the House of Representatives. Guthrie and Schrader introduced the Protecting Access to Safe and Effective Medicines Act in the Ho... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Republican Leader of the Energy and Commerce Committee’s Health Subcommittee, is working to reverse the substance use disorder crisis in the United States. Guthrie joined H.R. 1910, the Federal Initiative to Guarantee Health by Targeting Fentanyl Act, to extend the fentanyl analogues ban permanently. Fentanyl and its analogues are synthetic opi... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) announced Western Kentucky University has received a $429,768 research grant from the National Institutes of Health (NIH). The grant was awarded to WKU to advance biology professor Noah Ashley’s research into how sleep loss from stress and other factors causes inflammation, which can lead to other diseases such cancer and cardiovascular disease.... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) released the following statement after voting against the final version of the partisan $1.9 trillion COVID-19 bill. “I have and will continue to support resources for COVID-19 vaccines and other pandemic response efforts, but with less than 10% of this $1.9 trillion so-called COVID-19 bill going towards fighting COVID-19, I cannot support such ... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) released the following statement after voting against the partisan $1.9 trillion COVID-19 bill. Click HERE for video of Rep. Guthrie speaking against the partisan COVID-19 bill on House floor “I have proudly voted for five bipartisan COVID-19 bills that were signed into law,” said Guthrie. “I support targeted relief for people and small business... Read more »

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Republican Leader of the Energy and Commerce Committee’s Health Subcommittee, released the following statement after the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Johnson & Johnson’s COVID-19 vaccine. “With FDA’s authorization of Johnson & Johnson’s COVID-19 vaccine, we now have three safe COVID-19 vacci... Read more »